Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

UWCCC Molecular Tumor Board Registry

for
Hematologic Neoplasms, Solid Neoplasm
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT03023202

Recruiting
Active & Responsive

Biennial CEM in Women With a Personal History of Breast Cancer

for
Breast Cancer, Breast Neoplasms, Breast Cancer Female,
Location: Monroeville PA, West Mifflin PA, Pittsburgh PA,
Sponsor: Wendie Berg

Sex: Female

Age: 30 - 70+

Code: NCT06105749

Recruiting
Active & Responsive

68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study

for
Solid Cancers
Location: Sherbrooke
Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Sex: All

Age: 0+

Code: NCT05228106

Recruiting
Active & Responsive

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumor
Location: Canton OH, Cleveland OH
Sponsor: Lamassu Bio Inc

Sex: All

Age: 18+

Code: NCT06578624

Phase 1, Phase 2, Recruiting
Active & Responsive

Yoga for Young Adults Affected by Cancer

for
Young Adult Cancer, Young Adult Oncology
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT05314803

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

PAS-004 in Patients With Advanced Solid Tumors

for
RAS Mutation, NF1 Mutation, RAF Mutation, Advanced Solid Tumors
Location: Fairfax VA, San Antonio TX
Sponsor: Pasithea Therapeutics Corp.

Sex: All

Age: 18+

Code: NCT06299839

Phase 1, Recruiting
Active & Responsive

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

for
Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06066424

Phase 1, Recruiting
Active & Responsive

Multisite Implementation of COMPRENDO

for
Pediatric Cancer
Location: Boston MA, Birmingham AL, San Diego CA,
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT06055296

Recruiting
Active & Responsive

Biomarkers to Detect Endocrine Therapy Resistance

for
Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT06067503

Phase 2, Recruiting
Active & Responsive

CARE Study: Cancer, Asian Americans, and Relationship Enrichment

for
Neoplasm
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 21 - 70+

Code: NCT06782581

Recruiting
Active & Responsive

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

for
Solid Tumor, KRAS Mutation-Related Tumors
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT05661201

Phase 1, Recruiting
Active & Responsive

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

for
Localized Renal Pelvis and Ureter Urothelial Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT01050504

Recruiting
Active & Responsive

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

for
Cancer, Adjustment Disorders
Location: Rockville MD
Sponsor: Sunstone Medical

Sex: All

Age: 18+

Code: NCT05584826

Phase 2, Recruiting
Active & Responsive

PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.

for
Frailty, Oncology Problem, Cognitive Impairment
Location: Halifax
Sponsor: Nova Scotia Health Authority

Sex: All

Age: 70+

Code: NCT06022666

Recruiting
Active & Responsive

A Study of PHST001 in Advanced Solid Tumors

for
Advanced Solid Tumors, Ovarian Cancer, Endometrial Cancer,
Location: Boston MA, New Haven CT, Lake Success NY, New York NY,
Sponsor: Pheast Therapeutics

Sex: All

Age: 18+

Code: NCT06840886

Phase 1, Recruiting
Active & Responsive

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

for
Solid Tumor
Location: Pittsburgh PA, Atlanta GA, St Louis MO, Houston TX
Sponsor: Emory University

Sex: All

Age: 1 - 30

Code: NCT04469530

Phase 2, Recruiting
Active & Responsive

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

for
Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome,
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 0+

Code: NCT03160274

Recruiting
Active & Responsive

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

for
Pulmonary Disease, Pulmonary Hypertension
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)

Sex: All

Age: 18 - 70+

Code: NCT01730092

Recruiting
Active & Responsive

A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Fairfax VA, Houston TX, Fort Worth TX, San Antonio TX,
Sponsor: Antares Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT07767474

Phase 1, Phase 2, Recruiting
Active & Responsive

REC-7735 in Participants With Solid Tumors

for
Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Irving TX
Sponsor: Recursion Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07819136

Phase 1, Phase 2, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial